Andrew Technologies
Tustin, California, United States
About Andrew Technologies
Andrew Technologies, LLC, is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology:tm:. The first product to utilize TLT was launched in 2003 by Alcon for cataract surgery. In 2012, the FDA cleared HydraSolve:registered: Lipoplasty System. Andrew Technologies also has an impressive research pipeline focused on stem cells and diabetes.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.9M
- Last round: Series Unknown (Dec 2015)
- Website: andrew-technologies.com
- Phone: +1 888959-7674
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/andrew-technologies-2496818 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.